Can Higher Plavix Dose Offset PPI Effect Versus Effient? Medco Wants To Know

Medco is launching a preliminary study to find out whether doubling the usual dose of Bristol-Myers Squibb's Plavix can offset the problem of reduced effectiveness that comes with concurrent use of a proton pump inhibitor and show that Plavix can still be as effective in certain patients as its newer and more expensive competitor, Effient.